AbCellera Biologics Inc.ABCLNASDAQ
Loading
Revenue ContractionContracting
Percentile Rank57
3Y CAGR-46.3%
5Y CAGR-20.3%
Studio
Year-over-Year Change

Total revenue from sales of goods and services

3Y CAGR
-46.3%/yr
vs +172.3%/yr prior
5Y CAGR
-20.3%/yr
Recent deceleration
Acceleration
-218.6pp
Decelerating
Percentile
P57
Within normal range
vs 5Y Ago
0.3x
Contraction
Streak
1 yr
Consecutive growthContracting
PeriodValueYoY Change
2025$75.13M+160.6%
2024$28.83M-24.2%
2023$38.02M-92.2%
2022$485.42M+29.4%
2021$375.20M+60.9%
2020$233.16M+1907.9%
2019$11.61M+31.5%
2018$8.83M-